Capricor Therapeutics Board of Directors, Key People and Executives

Health Care & Life Sciences » Biotechnology | Capricor Therapeutics Inc.

Capricor Therapeutics Inc. | Key People and Executives

Linda Marbán

President, Chief Executive Officer & Director

Frank Litvack

Executive Chairman

Joshua A. Kazam

Independent Director

David Brian Musket

Independent Director

Louis Manzo

Independent Director

George W. Dunbar

Independent Director

Earl M. Collier

Independent Director

Linda Marbán

President, Chief Executive Officer & Director

Anthony Bergmann

Chief Financial Officer

Jeffrey J. Rudy

Vice President-Clinical Operations

Deborah D. Ascheim

Chief Medical Officer

Rachel Smith

Vice President-Research & Development

Karen G. Krasney

Secretary, Executive VP & General Counsel

Thomas Lyle Copmann

VP-Regulatory Affairs & Drug Development

Frank Litvack

Executive Chairman

Joshua A. Kazam

Independent Director

David Brian Musket

Independent Director

Louis Manzo

Independent Director

George W. Dunbar

Independent Director

Earl M. Collier

Independent Director

View Profile

Address	8840 Wilshire Boulevard Beverly Hills California 90211 United States
Employees	-
Website	http://www.capricor.com
Updated	07/08/2019
Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded on November 20, 2013 and is headquartered in Beverly Hills, CA.